MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies. - Wikidata - awgldk - TriplyDB

MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.

MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.

http://www.wikidata.org/entity/Q37256672

about

Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume.Gene silencing: a therapeutic approach to combat influenza virus infections.Drosha as an interferon-independent antiviral factor.Silencing of neurotropic flavivirus replication in the central nervous system by combining multiple microRNA target insertions in two distinct viral genome regions The Mammalian response to virus infection is independent of small RNA silencing.Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs.Long-term survival of influenza virus infected club cells drives immunopathology Dual miRNA targeting restricts host range and attenuates neurovirulence of flaviviruses.Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response.Standing your ground to exoribonucleases: Function of Flavivirus long non-coding RNAs.Genome-wide analysis of aberrantly expressed microRNAs in bronchoalveolar lavage fluid from patients with silicosis.Antigen specific immune response in Chlamydia muridarum genital infection is dependent on murine microRNAs-155 and -182 Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species.How do viruses avoid inhibition by endogenous cellular microRNAs?Synthetic biology devices and circuits for RNA-based 'smart vaccines': a propositional review.Investigating influenza A virus infection: tools to track infection and limit tropism.Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability.MicroRNA Regulation of RNA Virus Replication and Pathogenesis.The highly pathogenic H5N1 influenza A virus down-regulated several cellular MicroRNAs which target viral genome.MicroRNA-based Regulation of Picornavirus Tropism.Assessing and Managing the Risks of Potential Pandemic Pathogen Research.Risks and benefits of gain-of-function experiments with pathogens of pandemic potential, such as influenza virus: a call for a science-based discussion.Moratorium on research intended to create novel potential pandemic pathogens.microRNA-based attenuation of influenza virus across susceptible hosts.Infectious Diseases Society of America and Gain-of-Function Experiments With Pathogens Having Pandemic Potential.Gain-of-function experiments: time for a real debate.Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice.Are microRNAs Important Players in HIV-1 Infection? An Update.

P2860

Q28084005-3195F5EA-FF8B-4E34-9E4A-3E3B265374D4 Q30366406-8165E593-CB09-4E2B-9537-C9D0AA73677A Q30370880-B4F4D624-A391-401C-A3A3-2D47FD20BBA2 Q33627169-8AE34D83-55C1-4EFC-9BDD-5C539041E317 Q33821694-311125DF-8289-448E-AC72-3FC8214EA927 Q33894903-05A76FF7-8D3A-44CB-A966-C9B7888CEB71 Q33900325-CCDC1704-6320-42B4-ABF2-410C483CC3D9 Q34089130-3C43E2D9-A243-4099-B6F2-11CFB0F4B794 Q35532741-B6F1635D-8542-4DB0-A0C1-C591B0ED6ECA Q36304385-27515DD6-62B4-4A5C-BCB9-49157F331328 Q36553913-29A6446B-879C-4D85-870B-7B5DF54C0B6F Q37132157-F516CCA7-0658-42F0-8414-6E51F85304BE Q37662122-A3101192-7A9F-4652-91BA-32FD54C41967 Q37716213-5C285D88-5B92-4F2B-88FB-5692DDDBB569 Q38163528-10995E8E-7354-4EC2-BDF7-F382834969B2 Q38310499-C40F55B4-EDE1-4C9D-B9F9-27F3672FEE66 Q38412391-9ED6C650-3886-4AA7-9673-E2A8E112343F Q38728732-814E6B57-24EA-4A5B-B1E0-E8F903A2F8E2 Q38824253-20DF31C3-D603-4F08-909D-A67B24263309 Q39042688-BF804F17-88DC-4F9F-9E25-018FE33E1DFE Q40161983-EDB7F6F1-4D63-4D50-B970-23CCCF568EB3 Q40295203-4B359226-8C47-4EDE-9235-9237426BB1AF Q42382080-04EF67B6-543B-41F3-BC68-88AD061D95AA Q42781749-54971046-E1E6-4666-9DE9-DE1FA911F3A8 Q43072775-CAB16808-F18E-405C-B40B-EAA7A2BD9C5F Q43167859-268C3DAD-192C-4710-A4A3-51C5A7736CCA Q45019824-F3879A92-CE9C-43E9-BF0D-A77750FACE86 Q46249751-158161C8-819A-4BA8-8638-4CF12F84905E Q47210087-B303A21D-FA38-41B6-91FF-6D750F16733F Q52671487-54FD8FEA-894C-4304-B6BD-47A81B84772D

P2860

MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.

http://www.wikidata.org/entity/Q37256672

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.

@en

MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.

@nl

type

label

MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.

@en

MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.

@nl

prefLabel

MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.

@en

MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.

@nl

P1433

Q37256672-D22CD703-9A9C-469D-9B36-03F8E2A67340

P1476

Q37256672-ACE97C7F-43EB-4461-932F-5EEA309A6B4E

P2093

Q37256672-0975B984-DA64-4E7D-B1AE-6F38F9B086DB

Q37256672-154A91F5-172D-44D4-ABED-2503A52CFBDF

Q37256672-228B087A-AA88-4F24-B9CD-CDC5147AA1B7

Q37256672-25958FF3-F4CF-4849-964E-7C3431767528

Q37256672-476EC641-FE65-4475-AACF-5AD3DE8BDD12

Q37256672-759AAA22-2969-4BFB-B603-FD2380AB45C0

Q37256672-A94A61DF-81B7-4F04-A3A6-3C6A0AC4DA7C

Q37256672-B27574C8-3DC7-4BD0-9E1F-CAF18EC617C9

Q37256672-DC97F94C-7C87-4BBE-9F84-B03F27E0FA24

P2860

Q37256672-18DE3A01-0428-458E-AB96-A07382D21DA5

Q37256672-1AA8E8F9-26F9-4CEB-84E4-1B38E21FCD7F

Q37256672-21D02BDC-5CCB-4154-8FC1-09CC87430B51

Q37256672-2C5454B0-9C79-4003-AC08-E072E9D46C27

Q37256672-2E5CB3FD-2A3F-4785-AE92-3FE46DDA5BFE

Q37256672-3B59E695-0250-4B9B-86F5-39AFF9E6C1BD

Q37256672-3E426634-E732-4E06-9EF0-BF026A0A896E

Q37256672-40E9D5B9-C782-438C-9383-565117C0B224

Q37256672-46F77EE3-C387-4A08-BD41-2BE8ED2D03E3

Q37256672-470F655E-6BB5-41D5-A989-A0334E760226

P2888

Q37256672-68BA5B63-BA9D-4313-905D-DC96711E0CE9

P304

Q37256672-05AD585D-F858-4BF2-91B2-86FE7F265552

P31

Q37256672-E292C129-D133-4C80-BF75-ED273E4CC72D

P356

Q37256672-20614B7A-B12D-4893-BCD4-A1F7821D79C7

P433

Q37256672-73490F1F-59B1-487B-A32F-4A8583034FA8

P478

Q37256672-170D7F54-0D73-4B4A-8E46-33FB596B2C3C

P50

Q37256672-47B2654E-5E64-4BE7-AB4B-5DD9BCB421D1

Q37256672-A138DA9D-1081-4861-9A31-D68CCCBDCC39

Q37256672-BAD6DFFD-A296-48DE-BE30-49A475A59BEB

Q37256672-E00D847C-5230-465B-9753-2AE6A53F6157

P577

Q37256672-E635DDE7-B2C6-4B82-B149-E7AD688746B5

P5875

Q37256672-74828D7B-14BE-447F-97F3-9CFD7470BEF5

P698

Q37256672-4EF93424-7EAB-4736-8C4D-6FF507186D18

P921

Q37256672-BADBC193-39FB-4A6E-8749-7153D07B8238

P932

Q37256672-74A55E27-3365-4CA6-B3F6-FD0051FAF74C

P356

P1433

Nature Biotechnology

P1476

MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.

@en

P2093

Benjamin R tenOever

http://www.w3.org/2001/XMLSchema#string

Brian Kimble

http://www.w3.org/2001/XMLSchema#string

Courtney Finch

http://www.w3.org/2001/XMLSchema#string

Jillian S Shapiro

http://www.w3.org/2001/XMLSchema#string

Kemin Xu

http://www.w3.org/2001/XMLSchema#string

Mark A Chua

http://www.w3.org/2001/XMLSchema#string

Matthew Angel

http://www.w3.org/2001/XMLSchema#string

Ryan A Langlois

http://www.w3.org/2001/XMLSchema#string

Troy Sutton

http://www.w3.org/2001/XMLSchema#string

P2860

Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza

Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model

Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination

Receptor binding by a ferret-transmissible H5 avian influenza virus

Characterization of the reconstructed 1918 Spanish influenza pandemic virus

Airborne transmission of influenza A/H5N1 virus between ferrets

Human infection with a novel avian-origin influenza A (H7N9) virus

Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential.

Influenza A viruses: new research developments.

The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host.

P2888

P304

844-847

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NBT.2666

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Adolfo García-Sastre

Daniel R. Perez

Randy A. Albrecht

Ana S Gonzalez-Reiche

P577

2013-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255735209

http://www.w3.org/2001/XMLSchema#string

P698

23934176

http://www.w3.org/2001/XMLSchema#string

P921

P932

3808852

http://www.w3.org/2001/XMLSchema#string